Steve Andrzejewski
Steve is a pharmaceutical industry veteran and experienced CEO with proven success in large corporations and in small start-up companies. He lead the launch of Claritin and the industry first DTC campaign for a Rx drug. Steve is an adjunct professor at NYU Stern School of Business teaching a course "The Business of Health and Medical Care". He is also an entrepreneur-in-Residence at Yale Ventures. Steve holds a BA degree from Hamilton College and a MBA degree from New York University’s Stern School of Business.